Arimidex and Periodontal disease - a phase IV clinical study of FDA data

Summary:

Periodontal disease is found among people who take Arimidex, especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Arimidex and have Periodontal disease. It is created by eHealthMe based on reports of 20,902 people who have side effects when taking Arimidex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

20,902 people reported to have side effects when taking Arimidex.
Among them, 114 people (0.55%) have Periodontal disease.

What is Arimidex?

Arimidex has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 21,848 Arimidex users for its effectiveness, alternative drugs and more.

What is Periodontal disease?

Periodontal disease (disease that attacks the gum and bone and around the teeth) is found to be associated with 948 drugs and 328 conditions by eHealthMe.

Number of Arimidex and Periodontal disease reports submitted per year:

Could Arimidex cause Periodontal disease?

* Approximation only. Some reports may have incomplete information.

Do you take Arimidex and have Periodontal disease?

Check whether Periodontal disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

Related studies

How severe was Periodontal disease and when was it recovered:

Periodontal disease in Arimidex

Expand to all the drugs that have ingredients of anastrozole:

Periodontal disease and drugs with ingredients of anastrozole (118 reports)

Alternative drugs to, pros and cons of Arimidex:

Arimidex (21,848 reports)

Common Arimidex side effects:

Joint pain: 2,439 reports
Pain: 1,882 reports
Hair loss: 1,719 reports
Fatigue (feeling of tiredness): 1,708 reports
Stress and anxiety: 1,406 reports
Weakness: 1,366 reports
Hot flush (sudden feelings of heat): 1,295 reports

Browse all side effects of Arimidex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Periodontal disease treatments and more:

Periodontal disease (3,389 reports)

COVID vaccines that are related to Periodontal disease:

Common drugs associated with Periodontal disease:

All the drugs that are associated with Periodontal disease:

Periodontal disease (948 drugs)

Common conditions associated with Periodontal disease:

All the conditions that are associated with Periodontal disease:

Periodontal disease (328 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on anastrozole (the active ingredients of Arimidex) and Arimidex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.